Skip to main content
DNA Labs India

16S rRNA Sequencing Test

DNA Labs India | ISO 9001:2015 Certified

16S rRNA Sequencing Test

Short Name: 16S rRNA Seq

Also known as: 16S Ribosomal RNA Sequencing, 16S rRNA Gene Sequencing, Bacterial 16S Sequencing, Microbiome 16S Analysis

16S rRNA Sequencing Test test available at DNA Labs India for ₹5,000. Uses 16S rRNA Gene Amplification (PCR), Next-Generation Sequencing (NGS), Bioinformatics Pipeline Analysis on Extracted DNA / Clinical Specimens (Body Fluids, Tissue, Stool, Swabs) samples. Results in Results are typically available within 2 weeks of sample receipt at the laboratory. You will be notified via your preferred communication channel (online portal, email, or WhatsApp) once the report is ready.. Free home collection in 300+ cities across India.

Molecular Diagnostic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of 16S rRNA Sequencing is to identify bacterial species present in a clinical or research sample by analyzing the 16S ribosomal RNA gene. This test is specifically designed to detect bacteria that are difficult or impossible to grow using standard culture methods, including slow-growing, fastidious, and obligate intracellular organisms. It serves as a critical diagnostic tool for culture-negative infections, fever of unknown origin, and deep-seated infections where rapid and accurate pathogen identification is essential for targeted therapy. Additionally, it is widely used in microbiome research to characterize the bacterial composition of various body sites, including the gut, skin, and oral cavity, supporting studies in inflammatory bowel disease, irritable bowel syndrome, and other microbiome-associated conditions.

Test Code
3397
Price
₹5,000
Sample Type
Extracted DNA / Clinical Specimens (Body Fluids, Tissue, Stool, Swabs)
Result Time
Results are typically available within 2 weeks of sample receipt at the laboratory. You will be notified via your preferred communication channel (online portal, email, or WhatsApp) once the report is ready.
Fasting Required
No
Method
16S rRNA Gene Amplification (PCR), Next-Generation Sequencing (NGS), Bioinformatics Pipeline Analysis
Step 1

Sample Collection

No fasting is required. Inform your doctor about any current medications, especially antibiotics, as they may affect bacterial DNA detection. Follow any specific sample collection instructions provided by your physician. Use only sterile containers provided by DNA Labs India for fluid and tissue samples.

Method: Sterile collection by trained healthcare professional

Step 2

Laboratory Analysis

A trained healthcare professional will collect the appropriate clinical specimen using sterile technique. Sample types include body fluids (CSF, synovial fluid, pleural fluid), pus, tissue biopsies, stool, and swabs from infection sites. The collection method varies based on sample type and clinical indication.

Step 3

Report Delivery

The collected sample is labeled, sealed, and transported under appropriate conditions to our laboratory. No special post-collection care is required for the patient. Results will be available within 2 weeks via the online portal, email, or WhatsApp.

Timeline: Results are typically available within 2 weeks of sample receipt at the laboratory. You will be notified via your preferred communication channel (online portal, email, or WhatsApp) once the report is ready.

Patient Instructions

1
Before the Test:No special preparation or fasting is required. Inform your doctor about any current medications, especially antibiotics, as prior antimicrobial therapy may reduce bacterial DNA yield and affect detection sensitivity. Follow any specific instructions provided regarding sample collection containers and timing.
2
During the Test:Sample collection is performed by a trained healthcare professional. The procedure varies based on sample type—this may include swab collection, fluid aspiration (e.g., CSF, synovial fluid), tissue biopsy, or stool collection. All procedures use sterile technique to minimize contamination.
3
After the Test:No special post-collection care is needed for the patient. The sample is transported to our ISO-certified laboratory under appropriate conditions. Results are typically available within 2 weeks and are delivered via the online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

The primary purpose of 16S rRNA Sequencing is to identify bacterial species present in a clinical or research sample by analyzing the 16S ribosomal RNA gene. This test is specifically designed to detect bacteria that are difficult or impossible to grow using standard culture methods, including slow-growing, fastidious, and obligate intracellular organisms. It serves as a critical diagnostic tool for culture-negative infections, fever of unknown origin, and deep-seated infections where rapid and accurate pathogen identification is essential for targeted therapy. Additionally, it is widely used in microbiome research to characterize the bacterial composition of various body sites, including the gut, skin, and oral cavity, supporting studies in inflammatory bowel disease, irritable bowel syndrome, and other microbiome-associated conditions.

How to Prepare

  • Use only sterile, leak-proof containers provided by DNA Labs India.
  • Label each sample clearly with patient name, date of collection, and sample type.
  • For fluid samples, avoid contamination with normal flora during collection.
  • Stool samples should be collected in the provided container without urine contamination.
  • Tissue samples should be placed in sterile saline or approved transport medium immediately after collection.
  • Extracted DNA should be transported in DNA-free tubes at appropriate temperature as advised.

Doctor's Notes

Reviewed by — MBBS, MD (Microbiology) · Reg. No. 27670

"As an Infectious Disease specialist, I frequently encounter cases where standard cultures fail to identify the causative pathogen. 16S rRNA sequencing has transformed our diagnostic approach in such scenarios—particularly in culture-negative endocarditis, prosthetic joint infections, and neurological infections. This test provides a culture-independent method to detect bacterial DNA, often resolving diagnostic dilemmas that would otherwise remain unsolved. I recommend this test when conventional microbiological methods are inconclusive, when patients present with chronic or recurrent infections, or when fastidious organisms are suspected. However, clinicians should note that this test identifies bacterial presence but does not replace antibiotic susceptibility testing. Results should always be interpreted in conjunction with the patient's clinical presentation and other laboratory findings."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeExtracted DNA / Clinical Specimens (Body Fluids, Tissue, Stool, Swabs)
Sample VolumeVariable based on sample type; minimum 200 µL for fluids, 100 mg for tissue
ContainerSterile leak-proof container; DNA-free transport tube for extracted DNA
Collection MethodSterile collection by trained healthcare professional

Sample Stability

Room Temperature (15–25°C)Up to 24 hours
Refrigerated (2–8°C)48–72 hours
Frozen (−20°C)Up to 6 months
Sample Rejection Criteria:
  • Leaking, unlabeled, or improperly labeled containers.
  • Samples stored beyond the recommended stability period.
  • Heavily contaminated samples that compromise analysis integrity.
  • Insufficient sample volume or quantity for DNA extraction.
  • Samples received without proper documentation or requisition form.

Understanding Your Results

The 16S rRNA sequencing report provides a comprehensive list of bacterial species identified in the submitted sample, along with their relative abundance and taxonomic classification. Results should be interpreted by a qualified healthcare professional in the context of the patient's clinical presentation, medical history, site of infection, and other laboratory findings. The presence of bacterial DNA does not always indicate active infection; clinical correlation is essential.
📊

A likely causative pathogen has been identified. Correlate with clinical presentation and consider targeted antimicrobial therapy in consultation with the treating physician.

📊

May indicate a polymicrobial infection or contamination with normal flora. Clinical correlation is essential to distinguish pathogens from commensal organisms based on the sample site.

📊

The sample may not contain bacteria, or the bacterial load is below the detection threshold. Consider alternative diagnoses including viral, fungal, or non-infectious etiologies.

📊

May explain a previously undiagnosed infection. Discuss findings with an infectious disease specialist to determine appropriate targeted therapy.

📊

Reduced microbial diversity may be associated with dysbiosis, inflammatory bowel disease, or recent antibiotic use. Clinical correlation and longitudinal assessment may be warranted.

⚠️ When to Consult a Doctor:

Consult your treating physician or an infectious disease specialist to interpret the results in the context of your clinical condition. Do not self-medicate or alter any treatment based solely on this report. If the test identifies an unexpected organism, seek specialist guidance for appropriate management.

Limitations

  • Cannot provide antibiotic susceptibility data; a separate culture and sensitivity test is required for antimicrobial guidance.
  • Taxonomic resolution may be limited to genus level for certain bacterial species due to conserved 16S gene regions.
  • Does not detect viruses, fungi, parasites, or other non-bacterial organisms.
  • Cannot distinguish between live (viable) and dead (non-viable) bacteria in the sample.
  • Results reflect bacterial DNA present at the time of collection and may not represent dynamic changes in the microbiome.

Risks & Considerations

  • Minimal risk associated with non-invasive sample collection (swab, stool).
  • For invasive sample types such as tissue biopsies or fluid aspirations, standard procedural risks (bleeding, infection, discomfort) apply and are managed by the collecting physician.
  • No direct risk from the DNA sequencing or bioinformatics analysis process itself.

Interfering Factors

  • Prior or concurrent antibiotic therapy may reduce bacterial DNA yield and affect species detection.
  • Sample contamination during collection can introduce extraneous bacterial DNA.
  • Presence of PCR inhibitors in the sample (e.g., blood, hemoglobin, certain chemicals) may affect DNA amplification.
  • Excessive sample storage time or improper storage conditions may degrade bacterial DNA.

Compare With Similar Tests

Test16S rRNA Sequencing
Comparison16S rRNA Sequencing

Frequently Asked Questions

Is fasting required before providing a sample for 16S rRNA sequencing?
No, fasting is not required for 16S rRNA sequencing. However, please follow any specific instructions provided by your doctor regarding sample collection, such as using sterile containers for urine or fluid samples.
How is 16S rRNA sequencing different from a standard bacterial culture?
A standard culture attempts to grow bacteria on a plate, but many bacteria are difficult or impossible to grow in a lab. 16S sequencing detects bacterial DNA directly from the sample, identifying both culturable and unculturable bacteria, providing a more complete picture of the infection.
What kind of samples can be sent for 16S rRNA sequencing?
We accept a wide variety of samples, including extracted DNA, body fluids (CSF, synovial fluid, pleural fluid), pus, tissues, stool, and swabs from infection sites. Please contact us to confirm sample suitability for your specific case.
How accurate is 16S rRNA sequencing?
The test is highly accurate for bacterial identification. When performed in an ISO 9001:2015 certified laboratory with proper bioinformatics analysis, it can identify bacteria with a high degree of precision, often resolving cases where standard cultures are negative.
How do I book a 16S rRNA sequencing test?
You can book directly on this page by clicking the 'Book Now' button, or by calling our 24/7 customer support number. We will coordinate free home sample collection and answer any pre-test questions you may have.
Will the report tell me which antibiotic to use?
16S rRNA sequencing identifies the bacteria present in the sample. While it can sometimes inform treatment decisions based on the species identified, it is not a substitute for formal antibiotic susceptibility testing (AST). For antibiotic choices, this test is often used in conjunction with clinical assessment and other laboratory findings.
Is my sample and data kept private?
Yes, 100%. DNA Labs India adheres to strict confidentiality protocols. Your genetic data and personal information are securely stored and never shared without your explicit consent, in compliance with applicable data protection regulations.
Can this test be used for research purposes?
Absolutely. 16S sequencing is a cornerstone of microbiome research. We offer specialized services for research cohorts, including detailed bioinformatics analysis of microbial communities. Please contact our research support team for customized project quotes.
How long are the results valid?
The result is a snapshot of the bacterial DNA present in the sample at the time of collection. For diagnostic purposes, it directly informs immediate clinical management. For research, the data serves as a permanent record of that sample's bacterial composition.
What is the difference between 16S rRNA and Whole Genome Sequencing (WGS)?
16S sequencing targets a single gene to identify which bacteria are present. It is faster and more cost-effective for bacterial community analysis. Whole Genome Sequencing sequences all the DNA in a sample, providing deeper functional insights including resistance genes, but at a higher cost and complexity.
Can 16S rRNA sequencing detect antibiotic resistance genes?
16S rRNA sequencing is primarily designed for bacterial identification, not resistance gene detection. While the identified species may suggest known resistance patterns, formal antibiotic resistance profiling requires Whole Genome Sequencing or phenotypic susceptibility testing. Consult your physician for comprehensive resistance evaluation.
Is this test suitable for pediatric patients?
Yes, 16S rRNA sequencing can be performed on samples from patients of all ages, including pediatric patients. The test analyzes bacterial DNA from the submitted sample and does not require age-specific protocols. Sample collection in children should be performed by a trained pediatric healthcare professional.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.